{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T18:19:09Z","timestamp":1787681949669,"version":"build-2784847793"},"reference-count":142,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology","doi-asserted-by":"publisher","award":["PDF\/2016\/000894"],"award-info":[{"award-number":["PDF\/2016\/000894"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.dsx.2019.06.005","type":"journal-article","created":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T10:57:16Z","timestamp":1559991436000},"page":"2409-2417","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":124,"title":["An update on metabolic syndrome: Metabolic risk markers and adipokines in the development of metabolic syndrome"],"prefix":"10.1016","volume":"13","author":[{"given":"Reena","family":"Kumari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Kant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dsx.2019.06.005_bib1","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1161\/ATVBAHA.107.151092","article-title":"Metabolic syndrome pandemic","volume":"28","author":"Grundy","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.dsx.2019.06.005_bib2","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2337\/diacare.24.4.683","article-title":"Cardiovascular morbidity and mortality associated with the metabolic syndrome","volume":"24","author":"Isomaa","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2019.06.005_bib3","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1001\/jama.288.21.2709","article-title":"The metabolic syndrome and total and coronary heart disease mortality in middle-aged men","volume":"288","author":"Lakka","year":"2002","journal-title":"JAMA, J Am Med Assoc"},{"key":"10.1016\/j.dsx.2019.06.005_bib4","first-page":"11","article-title":"The relation of insulin resistance syndromes to risk of cardiovascular disease","volume":"4","author":"Nesto","year":"2003","journal-title":"Rev Cardiovasc Med"},{"key":"10.1016\/j.dsx.2019.06.005_bib5","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1161\/01.CIR.0000080897.52664.94","article-title":"Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the west of Scotland coronary prevention study","volume":"108","author":"Sattar","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.dsx.2019.06.005_bib6","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/archinte.164.10.1092","article-title":"Cardiorespiratory fitness attenuates the effects of the metabolic syndrome on all-cause and coronary heart disease mortality in men","volume":"164","author":"Katzmarzyk","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.dsx.2019.06.005_bib7","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1136\/bmj.39484.636586.94","article-title":"Should we dump the metabolic syndrome?","volume":"336","author":"Alberti","year":"2008","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.dsx.2019.06.005_bib8","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2337\/diacare.14.3.173","article-title":"Insulin resistance. a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease","volume":"14","author":"DeFronzo","year":"1991","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2019.06.005_bib9","series-title":"Definition, diagnosis and classification of diabetes mellitus and its complications","author":"WHO","year":"1999"},{"key":"10.1016\/j.dsx.2019.06.005_bib10","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1046\/j.1464-5491.1999.00059.x","article-title":"Comment on the provisional report from the WHO consultation. European group for the study of insulin resistance (EGIR)","volume":"16","author":"Balkau","year":"1999","journal-title":"Diabet Med"},{"key":"10.1016\/j.dsx.2019.06.005_bib11","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)","volume":"285","author":"NCEP","year":"2001","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.dsx.2019.06.005_bib12","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: an American heart association\/national heart, lung, and blood institute scientific statement","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.dsx.2019.06.005_bib13","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","article-title":"The metabolic syndrome\u2013 a new worldwide definition. IDF epidemiology task force consensus group","volume":"366","author":"Alberti","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.dsx.2019.06.005_bib14","series-title":"Type 2 diabetes in South Asians. Epidemiology, risk factors and prevention","first-page":"76","article-title":"The metabolic syndrome in South Asians","author":"Misra","year":"2006"},{"key":"10.1016\/j.dsx.2019.06.005_bib15","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.diabres.2004.11.018","article-title":"Prevalence and risk factors associated with the metabolic syndrome and dyslipidaemia in white, black, amerindian and mixed hispanics in zulia state, Venezuela","volume":"69","author":"Florez","year":"2005","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.dsx.2019.06.005_bib16","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ijcard.2007.07.097","article-title":"Metabolic syndrome determinants in an urban population from Brazil: social class and gender-specific interaction","volume":"129","author":"Marquezine","year":"2008","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.dsx.2019.06.005_bib17","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S1047-2797(00)00045-4","article-title":"Abdominal obesity and clustering of multiple factors in metabolic syndrome in white, black and hispanic Americans","volume":"10","author":"Okosun","year":"2000","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.dsx.2019.06.005_bib18","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1152\/ajpendo.90359.2008","article-title":"Adiponectin secretion and response to pioglitazone is depot dependent in cultured human adipose tissue","volume":"295","author":"Phillips","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.dsx.2019.06.005_bib19","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2337\/diab.37.12.1595","article-title":"Role of insulin resistance in human disease","volume":"37","author":"Reaven","year":"1988","journal-title":"Diabetes"},{"key":"10.1016\/j.dsx.2019.06.005_bib20","series-title":"Handbook of physiology, section 7 the endocrine system, vol. II the endocrine pancreas and regulation of metabolism","first-page":"1169","article-title":"Insulin resistance, compensatory hyperinsulinemia, and coronary heart disease: syndrome X revisited","author":"Reaven","year":"2001"},{"key":"10.1016\/j.dsx.2019.06.005_bib21","series-title":"Diabetes mellitus: a fundamental and clinical text. D LeRoith, SI taylor","first-page":"899","article-title":"Insulin resistance and its consequences","author":"Reaven","year":"2004"},{"key":"10.1016\/j.dsx.2019.06.005_bib22","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.jacc.2005.11.046","article-title":"Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds","volume":"47","author":"Grundy","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.dsx.2019.06.005_bib23","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.2337\/dc08-0423","article-title":"Metabolic syndrome and incident diabetes: current state of the evidence","volume":"31","author":"Ford","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2019.06.005_bib24","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.2337\/dc06-2484","article-title":"Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome","volume":"30","author":"Meigs","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2019.06.005_bib25","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.2337\/diabetes.51.10.3120","article-title":"Components of the \u201cmetabolic syndrome\u201d and incidence of type 2 diabetes","volume":"51","author":"Hanson","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.dsx.2019.06.005_bib26","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1161\/01.ATV.20.2.538","article-title":"Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men: the 22-year follow-up results of the helsinki policemen study","volume":"20","author":"Pyorala","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.dsx.2019.06.005_bib27","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1001\/jama.286.20.2516","article-title":"Gestational diabetes mellitus","volume":"286","author":"Jovanovic","year":"2001","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.dsx.2019.06.005_bib28","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.2337\/diacare.25.10.1862","article-title":"Gestational diabetes and the incidence of type 2 diabetes: a systematic review","volume":"25","author":"Kim","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2019.06.005_bib29","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1161\/01.ATV.15.11.1819","article-title":"Triglycerides are major determinants of cholesterol esterification\/transfer and HDL remodeling in human plasma","volume":"15","author":"Murakami","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.dsx.2019.06.005_bib30","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/01.CIR.82.2.495","article-title":"Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk","volume":"82","author":"Austin","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.dsx.2019.06.005_bib31","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s11892-004-0074-9","article-title":"Endothelial dysfunction, inflammation and insulin resistance: a focus on subjects at risk for type 2 diabetes","volume":"4","author":"Caballero","year":"2004","journal-title":"Curr Diabetes Rep"},{"key":"10.1016\/j.dsx.2019.06.005_bib32","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/00004872-200401000-00003","article-title":"Worldwide prevalence of hypertension: a systematic review","volume":"22","author":"Kearney","year":"2004","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.dsx.2019.06.005_bib33","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0140-6736(94)91285-8","article-title":"Epidemiology of hypertension","volume":"344","author":"Whelton","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.dsx.2019.06.005_bib34","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S0025-7125(05)70568-X","article-title":"Epidemiology and prevention of hypertension","volume":"81","author":"He","year":"1997","journal-title":"Med Clin N Am"},{"key":"10.1016\/j.dsx.2019.06.005_bib35","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S0140-6736(02)11403-6","article-title":"Selected major risk factors and global and regional burden of disease","volume":"360","author":"Ezzati","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.dsx.2019.06.005_bib36","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1464-5491.1993.tb02002.x","article-title":"Evidence for an increase in the prevalence of known diabetes in a sample of an urban population in Greece","volume":"10","author":"Katsilambros","year":"1993","journal-title":"Diabet Med"},{"key":"10.1016\/j.dsx.2019.06.005_bib37","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s001250050668","article-title":"Rising prevalence of NIDDM in an urban population in India","volume":"40","author":"Ramachandran","year":"1997","journal-title":"Diabetologia"},{"key":"10.1016\/j.dsx.2019.06.005_bib38","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1161\/01.ATV.0000019404.65403.71","article-title":"Respiratory uncoupling lowers blood pressure through a leptin dependent mechanism in genetically obese mice","volume":"22","author":"Bernal-Mizrachi","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.dsx.2019.06.005_bib39","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1161\/HYPERTENSIONAHA.107.103077","article-title":"Hyperresistinemia is associated with coexistence of hypertension and type 2 diabetes","volume":"51","author":"Takata","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.dsx.2019.06.005_bib40","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2337\/diabetes.53.2007.S143","article-title":"Update on adipocyte hormones; regulation of energy balance and carbohydrate\/lipid metabolism","volume":"53","author":"Havel","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.dsx.2019.06.005_bib41","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1161\/01.ATV.0000099786.99623.EF","article-title":"Adiponectin and metabolic syndrome","volume":"24","author":"Matsuzawa","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.dsx.2019.06.005_bib42","doi-asserted-by":"crossref","first-page":"S253","DOI":"10.1301\/nr.2007.dec.S253-S259","article-title":"Inflammatory biomarkers and risk for myocardial infarction, stroke, diabetes and total mortality: implications for longevity","volume":"65","author":"Ridker","year":"2007","journal-title":"Nutr Rev"},{"key":"10.1016\/j.dsx.2019.06.005_bib43","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1748-1716.2005.01502.x","article-title":"The role of adipokines as regulators of skeletal muscle fatty acid metabolism and insulin sensitivity","volume":"186","author":"Dyck","year":"2006","journal-title":"Acta Physiol"},{"key":"10.1016\/j.dsx.2019.06.005_bib44","first-page":"551","article-title":"Inflammatory status and insulin resistance","volume":"5","author":"Grimble","year":"2002","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.dsx.2019.06.005_bib45","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1172\/JCI117936","article-title":"Increased adipose tissue expression of tumor necrosis factor alpha in human obesity and insulin resistance","volume":"95","author":"Hotamisligil","year":"1995","journal-title":"J\u00a0Clin Investig"},{"key":"10.1016\/j.dsx.2019.06.005_bib46","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1043-2760(00)00301-5","article-title":"Adipose tissue as an endocrine organ","volume":"11","author":"Ahima","year":"2000","journal-title":"Trends Endocrinol Metabol"},{"key":"10.1016\/j.dsx.2019.06.005_bib47","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jpeds.2007.09.010","article-title":"Metabolic syndrome in childhood predicts adult metabolic syndrome and type 2 diabetes mellitus 25 to 30 years later","volume":"152","author":"Morrison","year":"2008","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.dsx.2019.06.005_bib48","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.cell.2007.10.004","article-title":"Developmental origin of fat: tracking obesity to its source","volume":"131","author":"Gesta","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.dsx.2019.06.005_bib49","doi-asserted-by":"crossref","first-page":"C190","DOI":"10.1152\/ajpcell.1989.256.1.C190","article-title":"Insulin stimulates in\u00a0vivo cell proliferation in white adipose tissue","volume":"256","author":"Geloen","year":"1989","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.dsx.2019.06.005_bib50","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.cmet.2006.07.001","article-title":"Transcriptional control of adipocyte formation","volume":"4","author":"Farmer","year":"2006","journal-title":"Cell Metabol"},{"key":"10.1016\/j.dsx.2019.06.005_bib51","doi-asserted-by":"crossref","first-page":"672","DOI":"10.2337\/diabetes.54.3.672","article-title":"Differential responses of visceral and subcutaneous fat depots to nutrients","volume":"54","author":"FH Atzmon","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.dsx.2019.06.005_bib52","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1053\/meta.2001.21693","article-title":"Contributions of total body fat, abdominal subcutaneous adipose tissue compartments, and visceral adipose tissue to the metabolic complications of obesity","volume":"50","author":"Smith","year":"2001","journal-title":"Metabolism"},{"key":"10.1016\/j.dsx.2019.06.005_bib53","first-page":"20S","article-title":"Is visceral fat involved in the pathogenesis of the metabolic syndrome? Human model","volume":"1","author":"Jensen","year":"2006","journal-title":"Obesity"},{"key":"10.1016\/j.dsx.2019.06.005_bib54","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/ndt\/15.8.1115","article-title":"Leptin and blood pressure--is there a link?","volume":"15","author":"Stenvinkel","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.dsx.2019.06.005_bib55","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1038\/sj.ijo.0801506","article-title":"The role of lipoprotein lipase in adipose tissue development and metabolism","volume":"24","author":"Zechner","year":"2000","journal-title":"Int J Obes"},{"key":"10.1016\/j.dsx.2019.06.005_bib56","doi-asserted-by":"crossref","first-page":"14170","DOI":"10.1074\/jbc.274.20.14170","article-title":"Cloning of a unique lipase from endothelial cells extends the lipase gene family","volume":"274","author":"Hirata","year":"1999","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.dsx.2019.06.005_bib57","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1146\/annurev.nutr.18.1.331","article-title":"Nutritional and hormonal regulation of enzymes in fat synthesis: studies of fatty acid synthase and mitochondrial glycerol-3- phosphate acyltransferase gene transcription","volume":"18","author":"Sul","year":"1998","journal-title":"Annu Rev Nutr"},{"key":"10.1016\/j.dsx.2019.06.005_bib58","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.arcmed.2008.09.005","article-title":"White adipose tissue as endocrine organ and its role in obesity","volume":"39","author":"Va\u00b4zquez-Vela","year":"2008","journal-title":"Arch Med Res"},{"key":"10.1016\/j.dsx.2019.06.005_bib59","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.2337\/db08-0157","article-title":"Relationship of abdominal visceral and subcutaneous adipose tissue with lipoprotein particle number and size in type 2 diabetes","volume":"57","author":"Sam","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.dsx.2019.06.005_bib60","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0165-6147(03)00132-9","article-title":"Do regional differences in adipocyte biology provide new pathophysiological insights?","volume":"24","author":"Lafontan","year":"2003","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.dsx.2019.06.005_bib61","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1007\/s001250051560","article-title":"Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance","volume":"43","author":"Weyer","year":"2000","journal-title":"Diabetologia"},{"key":"10.1016\/j.dsx.2019.06.005_bib62","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/sj.ijo.0800770","article-title":"Adipose tissue as an endocrine and paracrine organ","volume":"22","author":"Mohamed-Ali","year":"1998","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.dsx.2019.06.005_bib63","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1079\/BJN20041213","article-title":"Adipokines: inflammation and the pleiotropic role of white adipose tissue","volume":"92","author":"Trayhurn","year":"2004","journal-title":"Br J Nutr"},{"key":"10.1016\/j.dsx.2019.06.005_bib64","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.2337\/db06-0540","article-title":"Fat depot-specific characteristics are retained in strains derived from single human preadipocytes","volume":"55","author":"Tchkonia","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.dsx.2019.06.005_bib65","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.2337\/dc07-9921","volume":"30","author":"Klein","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2019.06.005_bib66","doi-asserted-by":"crossref","first-page":"25651","DOI":"10.1074\/jbc.C100189200","article-title":"Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor gamma agonists","volume":"276","author":"Way","year":"2001","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.dsx.2019.06.005_bib67","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.2337\/diabetes.53.7.1671","article-title":"Regulation of resistin expression and circulating levels in obesity, diabetes, and fasting","volume":"53","author":"Rajala","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.dsx.2019.06.005_bib68","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/35053000","article-title":"The hormone resistin links obesity to diabetes","volume":"409","author":"Steppan","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.dsx.2019.06.005_bib69","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S1043-2760(01)00522-7","article-title":"Resistin and obesity-associated insulin resistance","volume":"13","author":"Steppan","year":"2002","journal-title":"Trends Endocrinol Metabol"},{"key":"10.1016\/j.dsx.2019.06.005_bib70","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1006\/bbrc.2001.6132","article-title":"Suppressed gene expression of adipocyte resistin in an insulin-resistant rat model probably by elevated free fatty acids","volume":"289","author":"Juan","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.dsx.2019.06.005_bib71","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/oby.2002.149","article-title":"Resistin and adiponectin expression in visceral fat of obese rats: effect of weight loss","volume":"10","author":"Milan","year":"2002","journal-title":"Obes Res"},{"key":"10.1016\/j.dsx.2019.06.005_bib72","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1126\/science.1092341","article-title":"Regulation of fasted blood glucose by resistin","volume":"303","author":"Banerjee","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.dsx.2019.06.005_bib73","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.2337\/db05-0615","article-title":"Loss of resistin improves glucose homeostasis in leptin deficiency","volume":"55","author":"Qi","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.dsx.2019.06.005_bib74","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1172\/JCI20785","article-title":"Adenovirus-mediated chronic \u201chyper-resistinemia\u201d leads to in\u00a0vivo insulin resistance in normal rats","volume":"114","author":"Satoh","year":"2004","journal-title":"J\u00a0Clin Investig"},{"key":"10.1016\/j.dsx.2019.06.005_bib75","doi-asserted-by":"crossref","first-page":"E57","DOI":"10.1152\/ajpendo.90744.2008","article-title":"Oligomeric resistin impairs insulin and AICAR-stimulated glucose uptake in mouse skeletal muscle by inhibiting GLUT4 translocation","volume":"297","author":"Jorgensen","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.dsx.2019.06.005_bib76","first-page":"1747","article-title":"Roles of adipocyte derived hormone adiponectin and resistin in insulin resistance of type 2 diabetes world","volume":"12","author":"Lu","year":"2006","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.dsx.2019.06.005_bib77","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cccn.2003.09.009","article-title":"Enzyme-linked immunosorbent assay for circulating human resistin: resistin concentrations in normal subjects and patients with type 2 diabetes","volume":"339","author":"Fujinami","year":"2004","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.dsx.2019.06.005_bib78","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1210\/jc.2003-031121","article-title":"Plasma resistin concentrations measured by enzyme-linked immunosorbent assay using a newly developed monoclonal antibody are elevated in individuals with type 2 diabetes mellitus","volume":"89","author":"Youn","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.dsx.2019.06.005_bib79","doi-asserted-by":"crossref","first-page":"5452","DOI":"10.1210\/jc.2002-021808","article-title":"Serum resistin (FIZZ3) protein is increased in obese humans","volume":"88","author":"Degawa-Yamauchi","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2 Pt B","key":"10.1016\/j.dsx.2019.06.005_bib80","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.imlet.2014.07.009","article-title":"Resistin 420C\/G gene polymorphism on circulating resistin, metabolic risk factors and insulin resistance in adult women","volume":"162","author":"Kumar","year":"2014","journal-title":"Immunol Lett"},{"key":"10.1016\/j.dsx.2019.06.005_bib81","doi-asserted-by":"crossref","first-page":"41529","DOI":"10.18632\/oncotarget.17561","article-title":"Association between serum resistin concentration and hypertension: a systematic review and meta-analysis","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.dsx.2019.06.005_bib82","first-page":"821","article-title":"Point-counterpoint: interleukin-6 does\/does not have a beneficial role in insulin sensitivity and glucose homeostasis","volume":"102","author":"Bastard","year":"2007","journal-title":"J\u00a0Appl Physiol"},{"key":"10.1016\/j.dsx.2019.06.005_bib83","first-page":"4196","article-title":"Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-\u03b1, in\u00a0vivo","volume":"82","author":"Mohamed-Ali","year":"1997","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.dsx.2019.06.005_bib84","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1126\/science.1160794","article-title":"A\u00a0stress signaling pathway in adipose tissue regulates hepatic insulin resistance","volume":"322","author":"Sabio","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.dsx.2019.06.005_bib85","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.2337\/db06-1656","article-title":"Visceral fat adipokine secretion is associated with systemic inflammation in obese humans","volume":"56","author":"Fontana","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.dsx.2019.06.005_bib86","first-page":"847","article-title":"Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid","volume":"83","author":"Fried","year":"1998","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.dsx.2019.06.005_bib87","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1161\/01.CIR.0000150391.38660.9B","article-title":"Multiple abnormalities in glucose and energy metabolism and coordinated changes in levels of adiponectin, cytokines, and adhesion molecules in subjects with metabolic syndrome","volume":"110","author":"Salmenniemi","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.dsx.2019.06.005_bib88","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1161\/01.ATV.0000208363.85388.8f","article-title":"Comparison of circulating adiponectin and proinflammatory markers regarding their association with metabolic syndrome in Japanese men","volume":"26","author":"Matsushita","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.dsx.2019.06.005_bib89","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/oby.2001.54","article-title":"Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion","volume":"9","author":"Vozarova","year":"2001","journal-title":"Obes Res"},{"key":"10.1016\/j.dsx.2019.06.005_bib90","doi-asserted-by":"crossref","first-page":"E745","DOI":"10.1152\/ajpendo.2001.280.5.E745","article-title":"Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance","volume":"280","author":"Kern","year":"2001","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.dsx.2019.06.005_bib91","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1172\/JCI1235","article-title":"Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats","volume":"101","author":"Okuno","year":"1998","journal-title":"J\u00a0Clin Investig"},{"key":"10.1016\/j.dsx.2019.06.005_bib92","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.2337\/db05-1404","article-title":"Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in\u00a0vitro via AMP-activated protein kinase","volume":"55","author":"Carey","year":"2006","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.dsx.2019.06.005_bib93","first-page":"64","article-title":"Signaling specificity of interleukin-6 action on glucose and lipid metabolism in skeletal muscle","volume":"33","author":"Al-Khalili","year":"2006","journal-title":"Mol Endocrinol"},{"issue":"1","key":"10.1016\/j.dsx.2019.06.005_bib94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mce.2009.07.031","article-title":"Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome","volume":"314","author":"Maury","year":"2010","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.dsx.2019.06.005_bib95","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/4165260","article-title":"Impact of intensive lifestyle modification on levels of adipokines and inflammatory biomarkers in metabolically healthy obese women","volume":"2019","author":"Gomez-Huelgas","year":"2019","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.dsx.2019.06.005_bib96","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1210\/jc.2008-2196","article-title":"In\u00a0vitro hyperresponsiveness to tumor necrosis factor-alpha contributes to adipokine dysregulation in omental adipocytes of obese subjects","volume":"94","author":"Maury","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.dsx.2019.06.005_bib97","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1172\/JCI117936","article-title":"Increased adipose tissue expression of tumor necrosis factor alpha in human obesity and insulin resistance","volume":"95","author":"Hotamisligil","year":"1995","journal-title":"J\u00a0Clin Investig"},{"key":"10.1016\/j.dsx.2019.06.005_bib98","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/j.1365-2362.2004.01414.x","article-title":"Weight reduction, but not a moderate intake of fish oil, lowers concentrations of inflammatory markers and PAI-1 antigen in obese men during the fasting and postprandial state","volume":"34","author":"Jellema","year":"2004","journal-title":"Eur J Clin Investig"},{"issue":"3","key":"10.1016\/j.dsx.2019.06.005_bib99","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1055\/s-2003-39075","article-title":"Interleukin-6 mRNA expression is stimulated by insulin, isoproterenol, tumour necrosis factor alpha, growth hormone, and IL-6 in 3T3-L1 adipocytes","volume":"35","author":"Fasshauer","year":"2003","journal-title":"Horm Metab Res"},{"issue":"4","key":"10.1016\/j.dsx.2019.06.005_bib100","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1006\/bbrc.2001.5874","article-title":"Tumor necrosis factor alpha is a negative regulator of resistin gene expression and secretion in 3T3-L1 adipocytes","volume":"288","author":"Fasshauer","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.dsx.2019.06.005_bib101","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.2337\/diabetes.51.11.3176","article-title":"Profiling gene transcription in\u00a0vivo reveals adipose tissue as an immediate target of tumor necrosis factor-alpha: implications for insulin resistance","volume":"51","author":"Ruan","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.dsx.2019.06.005_bib102","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nm1166","article-title":"Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB","volume":"11","author":"Cai","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.dsx.2019.06.005_bib103","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.febslet.2007.11.051","article-title":"TNF-alpha and adipocyte biology","volume":"582","author":"Cawthorn","year":"2008","journal-title":"FEBS Lett"},{"key":"10.1016\/j.dsx.2019.06.005_bib104","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/39335","article-title":"Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function","volume":"389","author":"Uysal","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.dsx.2019.06.005_bib105","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1007\/s10067-007-0539-8","article-title":"Impact of TNF inhibition on insulin resistance and lipids levels in patients with rheumatoid arthritis","volume":"26","author":"Tam","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.dsx.2019.06.005_bib106","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.2337\/diab.43.11.1271","article-title":"Tumor necrosis factor alpha: a key component of the obesity-diabetes link","volume":"43","author":"Hotamisligil","year":"1994","journal-title":"Diabetes"},{"key":"10.1016\/j.dsx.2019.06.005_bib107","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1126\/science.7678183","article-title":"Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance","volume":"259","author":"Hotamisligil","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.dsx.2019.06.005_bib108","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.2337\/diabetes.51.10.2929","article-title":"Tumor necrosis factor-alpha stimulates lipolysis in differentiated human adipocytes through activation of extracellular signal-related kinase and elevation of intracellular cAMP","volume":"51","author":"Zhang","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.dsx.2019.06.005_bib109","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/jcb.10565","article-title":"TNF-alpha induction of lipolysis is mediated through activation of the extracellular signal related kinase pathway in 3T3-L1 adipocytes","volume":"89","author":"Souza","year":"2003","journal-title":"J\u00a0Cell Biochem"},{"issue":"12","key":"10.1016\/j.dsx.2019.06.005_bib110","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1017\/S0007114515001038","article-title":"Cytokine and growth factor profiling in patients with the metabolic syndrome","volume":"113","author":"Mirhafez","year":"2015","journal-title":"Br J Nutr"},{"key":"10.1016\/j.dsx.2019.06.005_bib111","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.cyto.2018.04.035","article-title":"Promoter variants of TNF-\u03b1 rs1800629 and IL-10 rs1800871 are independently associated with the susceptibility of coronary artery disease in north Indian","volume":"110","author":"Kumari","year":"2018","journal-title":"Cytokine"},{"issue":"3","key":"10.1016\/j.dsx.2019.06.005_bib112","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.dsx.2017.09.006","article-title":"TNF-\u03b1\/IL-10 ratio: An independent predictor for coronary artery disease in North Indian population","volume":"12","author":"Kumari","year":"2018","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.dsx.2019.06.005_bib113","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1196\/annals.1367.013","article-title":"Peripheral factors in the metabolic syndrome: the pivotal role of adiponectin","volume":"1083","author":"Tsatsanis","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.dsx.2019.06.005_bib114","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.1210\/jc.2002-020694","article-title":"Plasma adiponectin concentrations in children: relationships with obesity and insulinemia","volume":"87","author":"Stefan","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.dsx.2019.06.005_bib115","doi-asserted-by":"crossref","first-page":"536","DOI":"10.2337\/diabetes.51.2.536","article-title":"Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population","volume":"51","author":"Kadowaki","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.dsx.2019.06.005_bib116","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/90984","article-title":"The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity","volume":"7","author":"Kadowaki","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.dsx.2019.06.005_bib117","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/nm788","article-title":"Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase","volume":"8","author":"Yamauchi","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.dsx.2019.06.005_bib118","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0140-6736(02)09335-2","article-title":"Adiponectin and development of type 2 diabetes in the Pima Indian population","volume":"360","author":"Lindsay","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.dsx.2019.06.005_bib119","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0140-6736(03)12255-6","article-title":"Adiponectin and protection against type 2 diabetes mellitus","volume":"361","author":"Spranger","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.dsx.2019.06.005_bib120","doi-asserted-by":"crossref","first-page":"307","DOI":"10.7326\/0003-4819-149-5-200809020-00005","article-title":"Total and high-molecular-weight adiponectin and resistin in relation to the risk for type 2 diabetes in women","volume":"149","author":"Heidemann","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.dsx.2019.06.005_bib121","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.2337\/diabetes.51.7.2325","article-title":"Association of adiponectin mutation with type 2 diabetes: a candidate gene for the insulin resistance syndrome","volume":"51","author":"Kondo","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.dsx.2019.06.005_bib122","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.mce.2004.03.002","article-title":"Lower expression of adiponectin mRNA in visceral adipose tissue in lean and obese subjects","volume":"219","author":"Lihn","year":"2004","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.dsx.2019.06.005_bib123","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1161\/01.CIR.103.8.1057","article-title":"Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages","volume":"103","author":"Ouchi","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.dsx.2019.06.005_bib124","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1161\/01.CIR.102.11.1296","article-title":"Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway","volume":"102","author":"Ouchi","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.dsx.2019.06.005_bib125","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1210\/jc.2003-031777","article-title":"Adiponectin relationship with lipid metabolism is independent of body fat mass: evidence from both cross-sectional and intervention studies","volume":"89","author":"Baratta","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.dsx.2019.06.005_bib126","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/sj.ijo.0802594","article-title":"TNFalpha release by the nonfat cells of human adipose tissue","volume":"28","author":"Fain","year":"2004","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.dsx.2019.06.005_bib127","doi-asserted-by":"crossref","first-page":"10697","DOI":"10.1074\/jbc.271.18.10697","article-title":"AdipoQ is a novel adipose-specific gene dysregulated in obesity","volume":"271","author":"Hu","year":"1996","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.dsx.2019.06.005_bib128","doi-asserted-by":"crossref","first-page":"547","DOI":"10.2337\/diacare.27.2.547","article-title":"Adiponectin in youth: relationship to visceral adiposity, insulin sensitivity, and beta-cell function","volume":"27","author":"Bacha","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2019.06.005_bib129","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.imlet.2018.01.008","article-title":"Association of Leptin: Adiponectin ratio and metabolic risk markers in postmenopausal women","volume":"196","author":"Gupta","year":"2018","journal-title":"Immunol Lett."},{"key":"10.1016\/j.dsx.2019.06.005_bib130","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/372425a0","article-title":"Positional cloning of the mouse obese gene and its human homologue","volume":"372","author":"Zhang","year":"1994","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.dsx.2019.06.005_bib131","first-page":"194","article-title":"Adipose tissue as an endocrine organ: impact on insulin resistance","volume":"61","author":"Jazet","year":"2003","journal-title":"Neth J Med"},{"key":"10.1016\/j.dsx.2019.06.005_bib132","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nn1454","article-title":"Molecular and anatomical determinants of central leptin resistance","volume":"8","author":"Munzberg","year":"2005","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.dsx.2019.06.005_bib133","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cmet.2008.12.004","article-title":"Endoplasmic reticulum stress plays a central role in development of leptin resistance","volume":"9","author":"Ozcan","year":"2009","journal-title":"Cell Metabol"},{"key":"10.1016\/j.dsx.2019.06.005_bib134","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1172\/JCI30910","article-title":"Disruption of leptin receptor expression in the pancreas directly affects beta cell growth and function in mice","volume":"117","author":"Morioka","year":"2007","journal-title":"J\u00a0Clin Investig"},{"key":"10.1016\/j.dsx.2019.06.005_bib135","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/0014-5793(95)00943-4","article-title":"Diet- and diabetes-induced changes of ob gene expression in rat adipose tissue","volume":"371","author":"Becker","year":"1995","journal-title":"FEBS Lett"},{"key":"10.1016\/j.dsx.2019.06.005_bib136","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.2337\/diabetes.47.9.1384","article-title":"Depot-related gene expression in human subcutaneous and omental adipocytes","volume":"47","author":"Montague","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/j.dsx.2019.06.005_bib137","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1056\/NEJM199602013340503","article-title":"Serum immunoreactive-leptin concentrations in normal-weight and obese humans","volume":"334","author":"Considine","year":"1996","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.dsx.2019.06.005_bib138","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1172\/JCI118786","article-title":"The expression of ob gene is not acutely regulated by insulin and fasting in human abdominal subcutaneous adipose tissue","volume":"98","author":"Vidal","year":"1996","journal-title":"J\u00a0Clin Investig"},{"key":"10.1016\/j.dsx.2019.06.005_bib139","doi-asserted-by":"crossref","DOI":"10.1530\/JOE-14-0404","article-title":"20 years of leptin: connecting leptin signaling to biological function","volume":"223","author":"Allison","year":"2014","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.dsx.2019.06.005_bib140","doi-asserted-by":"crossref","DOI":"10.1152\/ajpendo.00274.2009","article-title":"Recent advances in understanding leptin signaling and leptin resistance","volume":"297","author":"Morris","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.dsx.2019.06.005_bib141","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.numecd.2017.04.003","article-title":"Analysis of the association of leptin and adiponectin concentrations with metabolic syndrome in children: results from the IDEFICS study","volume":"27","author":"Nappo","year":"2017","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.dsx.2019.06.005_bib142","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/415339a","article-title":"Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase","volume":"415","author":"Minokoshi","year":"2002","journal-title":"Nature"}],"container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402119303145?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402119303145?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T09:10:43Z","timestamp":1761729043000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402119303145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":142,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S1871402119303145"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2019.06.005","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An update on metabolic syndrome: Metabolic risk markers and adipokines in the development of metabolic syndrome","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2019.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd on behalf of Diabetes India.","name":"copyright","label":"Copyright"}]}}